| 1 |
DeSimone CV, Graff-Radford J, El-Harasis MA, et al. Cerebral amyloid angiopathy and implications for atrial fibrillation management [J]. Lancet, 2017, 390(10089): 9-11.
|
| 2 |
Ntaios G, Perlepe K, Lambrou D, et al. Identification of patients with embolic stroke of undetermined source and low risk of new incident atrial fibrillation: the AF-ESUS score [J]. Int J Stroke, 2021, 16(1): 29-38.
|
| 3 |
Geisler T, Poli S, Meisner C, et al. Apixaban for treatment of embolic stroke of undetermined source (ATTICUS randomized trial): rationale and study design [J]. Int J Stroke, 2017, 12(9): 985-990.
|
| 4 |
Huang WY, Ovbiagele B, Lee M. Oral anticoagulants vs antiplatelets in cryptogenic stroke with potential cardiac emboli: meta-analysis [J]. Eur J Internal Med, 2022, 95: 44-49.
|
| 5 |
Hart RG, Sharma M, Mundl H, et al. Rivaroxaban for stroke prevention after embolic stroke of undetermined source [J]. N Engl J Med, 2018, 378(23): 2191-2201.
|
| 6 |
Haeusler KG, Wilson D, Fiebach JB, et al. Brain MRI to personalise atrial fibrillation therapy: current evidence and perspectives [J]. Heart, 2014, 100(18): 1408.
|
| 7 |
Greenberg SM, Vernooij MW, Cordonnier C, et al. Cerebral microbleeds: a guide to detection and interpretation [J]. Lancet Neurol, 2009, 8(2): 165-174.
|
| 8 |
Yubi T, Hata J, Ohara T, et al. Clinical significance of Magnetic Resonance Imaging makers of vascular brain injury, a systematic review and Meta-anylasis [J]. JAMA Neurol, 2018, 10(28): E1-E14.
|
| 9 |
Yubi T, Hata J, Ohara T, et al. Prevalence of and risk factors for cerebral microbleeds in a general Japanese elderly community [J]. Neurol Clin Pract, 2018, 8(3): 223-231.
|
| 10 |
Akoudad S, Portegies MLP, Koudstaal PJ, et al. Cerebral microbleeds are associated with an increased risk of stroke: the Rotterdam study [J]. Circulation, 2015, 132(6): 509-516.
|
| 11 |
Charidimou A, Kakar P, Fox Z, et al. Cerebral microbleeds and recurrent stroke risk: systematic review and meta-analysis of prospective ischemic stroke and transient ischemic attack cohorts [J]. Stroke, 2013, 44(4): 995-1001.
|
| 12 |
蒋在军, 王田, 刘辉. 脑微出血与不常见疾病相关性的研究进展 [J/OL]. 中华脑血管病杂志(电子版), 2020, 14(3): 172-174.
|
| 13 |
Poels MM, Vernooij MW, Ikram MA, et al. Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study [J]. Stroke J Cereb Circ, 2010, 41(10 Suppl): S103-S106.
|
| 14 |
Horstmann S, Möhlenbruch M, Wegele C, et al. Prevalence of atrial fibrillation and association of previous antithrombotic treatment in patients with cerebral microbleeds [J]. Eur J Neurol, 2015, 22(10): 1355-1362.
|
| 15 |
Akoudad S, Darweesh SK, Leening MJ, et al. Use of coumarin anticoagulants and cerebral microbleeds in the general population [J]. Stroke J Cereb Circ, 2014, 45(11): 3436-3439.
|
| 16 |
Lovelock CE, Cordonnier C, Naka H, et al. Antithrombotic drug use, cerebral microbleeds, and intracerebral hemorrhage: a systematic review of published and unpublished studies [J]. Stroke, 2010, 41(6): 1222-1228.
|
| 17 |
Song TJ, Kim J, Song D, et al. Association of cerebral microbleeds with mortality in stroke patients having atrial fibrillation [J]. Neurology, 2014, 83(15): 1308-1315.
|
| 18 |
Nam KW, Kwon HM, Lim JS, et al. The presence and severity of cerebral small vessel disease increases the frequency of stroke in a cohort of patients with large artery occlusive disease [J]. PLoS One, 2017, 12(10): e0184944.
|
| 19 |
Shoamanesh A, Hart RG, Connolly SJ, et al. Microbleeds and the effect of anticoagulation in patients with embolic stroke of undetermined source: an exploratory analysis of the NAVIGATE ESUS randomized clinical trial [J]. JAMA Neurol, 2021, 78(1): 11-20.
|
| 20 |
Gregoire SM, Brown MM, Kallis C, et al. MRI detection of new microbleeds in patients with ischemic stroke: five year cohort follow-up study [J]. Stroke, 2010, 41(1): 184-186.
|
| 21 |
孙伟, 张玉生. 进退维谷: 心房颤动患者抗凝治疗相关出血后的卒中预防 [J]. 中国卒中杂志, 2021, 16(8): 757-761.
|
| 22 |
Kimura T, Tucker A, Nakagaki A, et al. Anticoagulation protocol for secondary prevention of acute ischemic stroke associated with nonvalvular atrial fibrillation [J]. J Stroke Cerebrovasc Dis, 2021, 30(8): 105893.
|
| 23 |
Kuno T, Takagi H, Ando T, et al. Oral anticoagulation for patients with atrial fibrillation on long-term hemodialysis [J]. J Am Coll Cardiol, 2020, 75(3): 273-285.
|
| 24 |
Pasquini M, Benedictus MR, Boulouis G, et al. Incident cerebral microbleeds in a cohort of intracerebral hemorrhage [J]. Stroke, 2016, 47(3): 689-694.
|
| 25 |
Lim JS, Hong KS, Kim GM, et al. Cerebral microbleeds and early recurrent stroke after transient ischemic attack: results from the Korean Transient Ischemic Attack Expression Registry [J]. JAMA Neurol, 2015, 72(3): 301-308.
|
| 26 |
Wilson D, Ambler G, Shakeshaft C, et al. Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study [J]. Lancet Neurol, 2018, 17(6): 539-547.
|
| 27 |
Imaizumi T, Inamura S, Kohama I, et al. Antithrombotic drug uses and deep intracerebral hemorrhages in stroke patients with deep cerebral microbleeds [J]. J Stroke Cerebrovasc Dis, 2013, 22(6): 869-875.
|
| 28 |
Thijs V, Lemmens R, Schoofs C, et al. Microbleeds and the risk of recurrent stroke [J]. Stroke, 2010, 41(9): 2005-2009.
|
| 29 |
Soo YO, Yang SR, Lam WW, et al. Risk vs benefit of anti-thrombotic therapy in ischaemic stroke patients with cerebral microbleeds [J]. J Neurol, 2008, 255(11): 1679-1686.
|
| 30 |
Smith EE, Saposnik G, Biessels GJ, et al. Prevention of stroke in patients with silent cerebrovascular disease: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association [J]. Stroke, 2017, 48(2): e44-e71.
|
| 31 |
Tsivgoulis G, Zand R, Katsanos AH, et al. Risk of symptomatic intracerebral hemorrhage after intravenous thrombolysis in patients with acute ischemic stroke and high cerebral microbleed burden: a meta-analysis [J]. JAMA Neurol, 2016, 73(6): 675-683.
|
| 32 |
O'donnell MJ, Eikelboom JW, Yusuf S, et al. Effect of apixaban on brain infarction and microbleeds: AVERROES-MRI assessment study [J]. Am Heart J, 2016, 178: 145-150.
|
| 33 |
Chairidimou A, Shoamanesh A, Al-Shahi Salman R, et al. Cerebral amyloid anbgiopathy, cerebral microbleeds and implications for anticoagulation decisions: the need for a balanced approach [J]. Int J Stroke, 2018, 13(2): 117-120.
|
| 34 |
Charidimou A, Imaizumi T, Moulin S, et al. Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: a meta-analysis [J]. Neurology, 2017, 89(8): 820-829.
|
| 35 |
Eckman MH, Rosand J, Knudsen KA, et al. Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis [J]. Stroke J Cereb Circ, 2003, 34(7): 1710-1716.
|
| 36 |
Kuramatsu JB, Gerner ST, Schellinger PD, et al. Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage [J]. JAMA J Am Med Assoc, 2015, 313(8): 824-836.
|
| 37 |
Horstmann S, Zugck C, Krumsdorf U, et al. Left atrial appendage occlusion in atrial fibrillation after intracranial hemorrhage [J]. Neurology, 2014, 82(2): 135-138.
|